share_log

Today's biggest pre-market stock movers: TSLA, CELZ, AFI and more

Today's biggest pre-market stock movers: TSLA, CELZ, AFI and more

今天最大的盤前股票推動者：特斯拉、CELZ、AFI等
Benzinga Real-time News ·  2022/01/03 07:35  · 異動

Gainers

贏家

  • $Creative Medical Technology(CELZ.US)$ rose 66.52% to $3.68 in pre-market trading after gaining around 8% on Friday.

  • $Armstrong Flooring(AFI.US)$ rose 39.9% to $2.77 in pre-market trading as the company said it received $35 million capital infusion, and announced process for sale of company and consideration of other strategic alternatives.

  • $BlueCity(BLCT.US)$ rose 21.57% to $1.87 in pre-market trading after the company reported receipt of a preliminary non-binding proposal to acquire the company.

  • $Cenntro Electric(NAKD.US)$ rose 7.28% to $5.75 in pre-market trading. Naked Brand recently completed acquisition of Cenntro Automotive Group.

  • $Tonix Pharmaceuticals(TNXP.US)$ rose 12.1% to $0.4010 in pre-market trading. Tonix Pharmaceuticals, last month, announced IND clearance for skin test (TNX-2100) to measure SARS-CoV-2 exposure and T Cell immunity.

  • $Innate Pharma(IPHA.US)$ rose 7.9% to $4.92 in pre-market trading. Innate Pharma was recently franted U.S. patent titled 'Multispecific antigen binding proteins.'

  • $Frontline(FRO.US)$ rose 7.6% to $7.61 in pre-market trading. Frontline, in November, reported third-quarter operating revenue of $171.8 million, a decline of 30.6% year-over-year.

  • $Tesla(TSLA.US)$ rose 7% to $1,131.03 in pre-market trading as the company reported record quarterly and annual deliveries that exceeded the most optimistic Wall Street forecasts.

  • $創新醫療技術(CELZ.US)$繼上週五上漲約8%後，該股在盤前交易中上漲66.52%，至3.68美元。

  • $阿姆斯特朗地板(AFI.US)$在盤前交易中，該公司股價上漲39.9%，至2.77美元，該公司表示已獲得3500萬美元的注資，並宣佈了出售公司的流程，並考慮了其他戰略選擇。

  • $BlueCity(BLCT.US)$在盤前交易中，該公司股價上漲21.57%，至1.87美元，此前該公司報告收到了收購該公司的初步不具約束力的提議。

  • $Cenntro Electric(NAKD.US)$在盤前交易中，該股上漲7.28%，至5.75美元。Naked Brand最近完成了對Cenntro Automotive Group的收購。

  • $Tonix PharmPharmticals(TNXP.US)$在盤前交易中，該公司股價上漲12.1%，至0.4010美元。上個月，Tonix製藥公司宣佈批准IND進行皮膚測試(TNX-2100)，以測量SARS-CoV-2暴露和T細胞免疫。

  • $InNatural Pharma(IPHA.US)$在盤前交易中，該股上漲7.9%，至4.92美元。InNatural Pharma公司最近獲得了一項名為“多特異性抗原結合蛋白”的美國專利。

  • $Frontline(FRO.US)$在盤前交易中上漲7.6%，至7.61美元。11月份，Frontline公佈第三季度營業收入為1.718億美元，同比下降30.6%。

  • $特斯拉(TSLA.US)$在盤前交易中，該公司股價上漲7%，至1131.03美元，該公司公佈的季度和年度交貨量創下紀錄，超過了華爾街最樂觀的預測。

Losers

失敗者

  • $AgeX Therapeutics(AGE.US)$ fell 16.2% to $0.9130 in pre-market trading after jumping 85% on Friday. AgeX Therapeutics recently announced plans to collaborate with University of California, Irvine, on research program for exosome-based therapies for certain brain disorders.

  • $Planet Green(PLAG.US)$ fell 13.7% to $0.88 in pre-market trading. Planet Green Holdings, last month, entered into share exchange agreement with Shandong Yunchu Supply Chain.

  • $CNH Industrial(CNHI.US)$ shares fell 11.6% to $17.18 in pre-market trading. CNH Industrial recently announced its Iveco subsidiary would become a standalone publicly traded company.

  • $Flex LNG(FLNG.US)$ fell 10.2% to $21.09 in pre-market trading.

  • $Medalist Diversified REIT Inc(MDRR.US)$ shares fell 8.3% to $1.10 in pre-market trading. Medalist Diversified REIT shares jumped around 18% on Friday after the company announced a stock repurchase program of 500,000 shares.

  • $SuperCom(SPCB.US)$ fell 6.9% to $0.5165 in pre-market trading after declining around 9% on Friday.

  • $Ocuphire Pharma(OCUP.US)$ fell 4.6% to $3.56 in pre-market trading.

  • $AgeX治療公司(AGE.US)$繼上週五大漲85%後，該股在盤前交易中下跌16.2%，至0.9130美元。AgeX治療公司最近宣佈，計劃與加州大學歐文分校合作，開展基於外周小體的治療某些大腦疾病的研究計劃。

  • $美國綠星球(PLAG.US)$在盤前交易中，該股下跌13.7%，至0.88美元。上個月，美國綠星球控股與山東雲楚供應鏈簽訂了換股協議。

  • $CNH工業(CNHI.US)$ 在盤前交易中，該公司股價下跌11.6%，至17.18美元。CNH工業最近宣佈，其子公司依維柯將成為一家獨立的上市公司。

  • $Flex LNG(FLNG.US)$在盤前交易中，該股下跌10.2%，至21.09美元。

  • $金牌獲得者多元化房地產投資信託基金公司(MDRR.US)$在盤前交易中，該公司股價下跌8.3%，至1.10美元。週五，在宣佈了一項50萬股的股票回購計劃後，金牌多元化房地產投資信託基金的股價上漲了約18%。

  • $SuperCom(SPCB.US)$繼上週五下跌約9%後，該股在盤前交易中下跌6.9%，至0.5165美元。

  • $Ocuphire Pharma(OCUP.US)$在盤前交易中下跌4.6%，至3.56美元。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論